PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine

Change in the IQWiG final report of 2009: Proof of a benefit for cognitive function; indications of a benefit for activities of daily living

2011-04-28
(Press-News.org) After the manufacturer of the Alzheimer's drug memantine submitted a supplementary analysis of study data, the German Institute for Quality and Efficiency in Health Care (IQWiG) sees proof of a benefit of the drug for cognitive function, as well as indications of a benefit for activities of daily living, at least for a treatment period of 6 months. This changes the conclusions of the first IQWiG benefit assessment of 2009. IQWiG had repeatedly called upon the manufacturer Merz to provide a renewed analysis of study data appropriate to the research question.

Additional effort may also be worthwhile for manufacturers

IQWiG's Director Jürgen Windeler comments on the new assessment result: "As in many other projects, in the assessment of memantine the Institute was also confronted with gaps in the evidence. If this is the case, then we make suggestions as to how these gaps can be closed. Sometimes additional new studies are required; sometimes it suffices if the manufacturer provides or supplements data already available, as was the case for memantine. In the end, the additional effort paid off."

In the first IQWiG assessment, data from two studies were missing

In Germany the drug memantine is marketed under the tradenames "Axura" and "Ebixa", and is approved for the treatment of moderate to severe Alzheimer's disease. In a first benefit assessment , prepared after commissioning by the Federal Joint Committee (G-BA) and published in September 2009, IQWiG found no proof that patients with Alzheimer's disease could benefit from memantine. However, among other things, relevant information on two studies was missing, which the manufacturer had not provided to IQWiG.

Additional analysis did not consider all of the relevant studies

At the beginning of 2010, Merz submitted the results of these two studies, as well as additional analyses of a larger number of studies, to the G-BA. IQWiG subsequently published a second assessment in the form of a working paper in August 2010. However, this did not change the conclusions of the first report. This was also due to the fact that IQWiG could not utilize the additional analyses as presented by Merz. For example, among other things, Merz had again failed to include all of the relevant studies. However, in its working paper IQWiG described how an appropriate analysis of the data could be performed.

Absence of deterioration may also mean an improvement

These additional analyses, in which the data were processed appropriately, were finally submitted by Merz to the G-BA in October 2010. These were "responder analyses". In this type of analysis, a count is made of how many patients experience a notable improvement in their health status after treatment, i.e. are "responders".

For this purpose it is specified how big this difference has to be in a patient in order to be classified as an improvement. Then, both in the placebo and in the memantine groups, all patients are counted who at least achieved this improvement. In the case of a progressive disease such as Alzheimer's, the absence of deterioration may also be regarded as an improvement.

Indications of a benefit for activities of daily living

As the analysis now submitted shows, the number of patients whose short- and long-term memory (cognitive function) notably deteriorated over a period of at most 6 months was lower in the memantine group. IQWiG classifies this result as proof of a benefit.

Such a difference in favour of memantine was also shown for activities of daily living (e.g. concerning personal hygiene); however, this was considerably smaller. In addition, in contrast to the outcome "cognitive function", the criteria according to which patients were classified as treatment responders have not proved themselves through year-long testing in studies. This leads to greater uncertainty in the interpretation of results. Consequently, overall IQWiG assumes an indication - not proof - of a benefit of treatment with memantine for this outcome.

Long-term studies are lacking

It remains unclear whether memantine improves quality of life, as for this outcome the studies available still allow no conclusions to be drawn. The results for cognitive function and activities of daily living now submitted only apply with time restrictions, as none of the studies lasted longer than 6 months. "We still have no long-term studies. However, particularly for Alzheimer's drugs this type of study is urgently required, as they are usually taken for several years," says Jürgen Windeler.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Andromeda's coat of many colors

2011-04-28
VIDEO: ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows... Click here for more information. ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows a different aspect of the galaxy's nature. Visible light, as seen ...

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation
2011-04-28
Atlanta pool service company Piranha Pool Management is recommending that homeowners in the Atlanta area properly prepare their pools for renewed use in the coming months. After going unused with minimal maintenance in the winter, pool preparation is essential before summertime. Piranha Pool Management provides comprehensive Atlanta pool maintenance and repair, including a summer start-up service. In temperate cities like Atlanta, pools are strongly affected by the change in seasons. In the fall, they are covered to keep out the falling leaves and dropping temperatures, ...

Americans still may not be getting enough calcium

2011-04-28
Philadelphia, PA, April 27, 2011 – Americans may not be getting enough calcium in their diets, according to a new study published in the May 2011 issue of the Journal of the American Dietetic Association. This study is unique among those focusing on calcium intake in the US population because both dietary and supplemental sources were evaluated across adult age groups and compared to accompanying patterns in energy intake. "Calcium plays a fundamental role in promoting bone health and forestalling osteoporosis. In light of evidence that energy intake declines with aging, ...

AGU journal highlights -- April 27, 2011

2011-04-28
The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL), the Journal of Geophysical Research-Space Physics (JGR-A), the Journal of Geophysical Research-Oceans (JGR-C), and the Journal of Geophysical Research-Biogeosciences (JGR-G). In this release: Could the cold winter of 2009-2010 have been predicted? Coastal cooling and marine productivity increasing off Peru Lightning radio-wave pattern tied to gamma ray flashes Analyzing peat's ability to trap methane bubbles Probe of influential Greenland current ...

Medical sleuthing linked muscle, kidney problems to kava tea

2011-04-28
When a 34-year-old bicyclist was found collapsed on a roadside and rushed to the University of Rochester Medical Center emergency room on the verge of kidney failure and muscle breakdown, doctors were surprised to discover that a trendy tea derived from the kava plant was the cause of his ills. The URMC team reported the case study, believed to be the first of its kind in the scientific literature, in the American Journal of Emergency Medicine. They described it as a cautionary tale, emphasizing the importance of taking a thorough medical history, including the use ...

For peacocks, the eyespots don't lie

For peacocks, the eyespots dont lie
2011-04-28
Male peacock tail plumage and courtship antics likely influence their success at attracting and mating with females, according to recent Queen's University research. Roz Dakin and Robert Montgomerie have found that natural variation in the number of eyespots on a peacock's tail does not impact a male's mating success. However, peacocks whose tails are clipped to considerably reduce the number of eyespots are less successful at mating. Female rejection of males with substantially fewer eyespots on their tails may have a number of explanations, including the perceived ...

Atlanta Moving Company Atlanta Peach Movers Named Official Mover for the Georgia Chapter of Women's Council of Realtors

Atlanta Moving Company Atlanta Peach Movers Named Official Mover for the Georgia Chapter of Womens Council of Realtors
2011-04-28
Atlanta moving company Atlanta Peach Movers is the official mover for the Georgia Chapter of the Women's Council of Realtors (WCR). Atlanta Peach Movers is a full-service moving company in Atlanta, managing local, long distance, and international moves. Atlanta Peach Movers works hand in hand with the Georgia WCR so that it can better address the relocation needs of metro Atlanta and Georgia. The Realtors and businesswoman who serve on the Georgia WCR have a reliable and quality resource in Atlanta Peach Movers to advocate for clients who are moving from Atlanta across ...

MIT: Advances in DNA 'origami'

2011-04-28
CAMBRIDGE, Mass. -- While the primary job of DNA in cells is to carry genetic information from one generation to the next, some scientists also see the highly stable and programmable molecule as an ideal building material for nanoscale structures that could be used to deliver drugs, act as biosensors, perform artificial photosynthesis and more. Trying to build DNA structures on a large scale was once considered unthinkable. But about five years ago, Caltech computational bioengineer Paul Rothemund laid out a new design strategy called DNA origami: the construction of ...

Researchers observe disruptions of daily rhythms in Alzheimer's patients' brains

2011-04-28
Twenty-four hour cycles, known as circadian rhythms, are important for proper body functions, including for normal brain function and mental health. Disruptions of circadian rhythms and sleep-wake cycles have been observed in patients with Alzheimer's disease. A new study by Douglas Institute researchers unravels a possible basis for these perturbations. First study to show function of clock genes in multiple areas of the human brain Until now, the genes contributing to this timing, known as clock genes, have only been found to be active in areas outside the brain, such ...

Researchers ID promising pancreatic cancer screening marker

Researchers ID promising pancreatic cancer screening marker
2011-04-28
ANN ARBOR, Mich. — Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease. The finding suggests a blood test could serve as a potential screening tool to detect pancreatic cancer – which has the worst prognosis of any cancer type – at an earlier, more treatable stage. "One of the difficulties in screening for pancreatic cancer is distinguishing ...

LAST 30 PRESS RELEASES:

Researchers link extreme heat and work disability among older, marginalized workers

Physician responses to patient expectations affect their income

Fertility preservation for patients with cancer

We should talk more at school: Researchers call for more conversation-rich learning as AI spreads

LHAASO uncovers mystery of cosmic ray "knee" formation

The simulated Milky Way: 100 billion stars using 7 million CPU cores

Brain waves’ analog organization of cortex enables cognition and consciousness, MIT professor proposes at SfN

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

AMP 2025 press materials available

New genetic test targets elusive cause of rare movement disorder

A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

[Press-News.org] Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine
Change in the IQWiG final report of 2009: Proof of a benefit for cognitive function; indications of a benefit for activities of daily living